Cerebrospinal fluid inflammatory markers in patients with Listeria monocytogenes meningitis

Merel M Koopmans1, Matthijs C Brouwer1, Madelijn Geldhoff1

  • 1Department of Neurology, Academic Medical Center, University of Amsterdam, Center for Infection and Immunity Amsterdam (CINIMA), Amsterdam, The Netherlands.

BBA Clinical
|May 12, 2015
PubMed

Insights

Immune responses involving T-cell activation, complement, interferon, and growth factors are key in Listeria meningitis. These pathways significantly influence patient outcomes and offer targets for future research.

Area of Science:

  • Neuroimmunology
  • Infectious Diseases
  • Meningitis Research

Background:

  • Listeria monocytogenes meningitis is a severe infection with high mortality and poor outcomes.
  • It is the third most common cause of bacterial meningitis.

Purpose of the Study:

  • To identify biomarkers in cerebrospinal fluid (CSF) associated with Listeria meningitis.
  • To compare biomarker profiles between patients and controls, and between favorable and unfavorable outcomes.

Main Methods:

  • Analysis of 101 cytokines, chemokines, and complement factors in CSF from adult Listeria meningitis patients and controls.
  • Prospective cohort study design.

Main Results:

  • CSF from 26 patients and 19 controls was analyzed.
  • 51 biomarkers were significantly elevated in Listeria meningitis patients compared to controls.
  • Eleven key biomarkers, including T-cell activation markers (sIL-2Rα, sCD40L, IL-1), interferon-related factors (IFN-α2, IL-18, CX3CL1, CCL20), complement activation marker (C3a), and endothelial growth factors (VEGF, CXCL7), were associated with unfavorable outcomes.

Conclusions:

  • T-cell activation, complement activation, interferon production, and endothelial growth factor signaling are crucial in the immune response to Listeria meningitis.
  • These pathways significantly impact patient prognosis and represent potential therapeutic targets.
Abstract